Analyst firms · Morgan Stanley · SNN

Morgan Stanley SNN price target and rating history

Smith & Nephew SNATS Inc. (SNN) · Health Care

Morgan Stanley rates Smith & Nephew SNATS Inc. (SNN) Equal-Weight, as of its latest action on Sep 2, 2026. It has published 3 rating actions on SNN since October 2022, including 1 upgrade and 1 downgrade.

Current rating
Equal-Weight
Price target
Not stated
Median target, all firms
Too few
Actions on SNN
3

Every Morgan Stanley rating on SNN

How other firms rate SNN

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
BofA SecuritiesNeutralSep 8, 2026
Morgan StanleyEqual-WeightSep 2, 2026
BTIGNeutralAug 31, 2026
BarclaysUnderweightAug 5, 2026
Kepler CheuvreuxHoldJun 4, 2026
RBC Capital MarketsSector PerformDec 15, 2025

Questions about Morgan Stanley and SNN

What is Morgan Stanley's rating on SNN?
Morgan Stanley rates SNN Equal-Weight, a neutral rating, as of Sep 2, 2026.
When did Morgan Stanley last change its view on SNN?
On Sep 2, 2026, Morgan Stanley downgrades to Equal-Weight from Overweight.

More SNN rating histories

All Morgan Stanley ratingsSNN news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.